Microsponges: A Promising Novel Drug Delivery System by Naga Jyothi, K. et al.
Naga Jyothi et el                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(5-s):188-194 
ISSN: 2250-1177                                                                                  [188]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.10.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                        Review Article  
Microsponges: A Promising Novel Drug Delivery System 
K. Naga Jyothi 1, P. Dinesh Kumar 1*, P. Arshad 1, M. Karthik 1, T. Panneerselvam 2 
1 Research Center in Pharmaceutics, Hindu College of Pharmacy, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.  
2 Department of Pharmaceutical Chemistry, Karavadi College of Pharmacy, Vamanjoor, Mangalore-575028 
 
ABSTRACT  
Microsponge is recent novel technique for control release and target specific drug delivery system. More and more developments in drug 
delivery systems are being integrated to optimize the efficacy and cost-effectiveness of the therapy. Microsponges are polymeric delivery 
system containing porous microspheres having a size range from 5 to 300µm. Microsponge Delivery System (MDS) is a unique technology for 
controlled drug delivery. This review article mainly deals with Microsponge drug delivery along with its method of preparation, 
characterization, advantages and release mechanism of MDS. Microsponges are characterized by particle size, entrapment efficacy, true density, 
% drug content and % yield, dissolution studies, Resiliency, compatibility studies and in-vitro studies. Wide range of applications is also 
preferred to develop drug with enhanced safety and efficacy.  
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Drug delivery system that can specifically control the release 
rate and target drugs to specific locations of the body have a 
major impact on the health care system [1]. They are 
polymeric and has large porous surface with a tiny sponge 
like spherical particles. Moreover, they reduce side effects, 
enhance stability and modify drug release favorably. 
Microsponge technology makes it a versatile drug delivery 
vehicle as it has many techniques. Microsponge Systems are 
based on microscopic, polymer-based microspheres that can 
suspend or entrap a wide variety of substances, and can then 
be incorporated into a formulated product [2]. Microsponges 
are also capable of delivering pharmaceutical active 
ingredients efficiently at a minimal dose to targeted site, 
which reduces severe systemic degradation [3, 4]. 
Microsponge delivery system (MDS) also known as solid 
phase porous microspheres as it is a patented micro 
particulate system, (Figure 1)[5] highly comprising cross-
linked, polymeric porous microspheres having numerous 
interconnected voids in the particle, loaded with active agent 
[6] within a non-collapsible structure [7] with large porous 
surface to entrap wide range of active agents with varying 
pharmacological activities administered in different doses 
that can be released at the desired site for absorption [8]. 
The size of the micro sponges ranges from 5-300μm in 
diameter and sphere can have up to 250000 pores. 
Microsponges are designed to deliver a pharmaceutical 
active ingredient efficiently at minimum dose, reduce side-
effect, enhance stability and also to modify drug release 
profile  This results in a large reservoir within each 
microsponge, which can be loaded with up to its own weight 
of active agent[9-11]. 
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Fig.1: Highly porous nature of microsponges 
 
Potential features of microsponge drug delivery 
systems [12-15]:  
1. Have stability at pH extending from 1 to 11.  
2. They are stable at temperature 130°C.  
3. Have self-sterilization due to pore size 0.2 5μm which 
prevents penetration of bacteria, thus they not require 
addition of a preservative.  
4. Have high loading capacity ranging from 50 to 60%.  
5. Free flow properties and can be productive in relation 
to its cost.  
6. Offer good compatibility with different vehicles and 
ingredients.  
Characteristics of actives moieties that is 
entrapped into microsponges [16, 17]: 
1. Active ingredients that are entrapped in microsponge can 
be incorporated into many products such as creams, gels, 
powders, lotions and soaps. 
2. Certain considerations are taken into account while, 
formulating the vehicle in order to achieve desired product 
characteristics. 
3. It should be either fully miscible in monomer as well as 
capable of being made miscible by addition of small amount 
of a water immiscible solvent. 
4. It should be inert to monomers and should not increase 
the viscosity of the mixture during formulation. 
5. It should be water immiscible or nearly only slightly 
soluble. 
6. It should not collapse spherical structure of the 
microsponges. 
7. It should be stable in contact with polymerization catalyst 
and also in conditions of polymerization. 
8. The solubility of actives in the vehicle must be limited. 
9. Payload and polymer design of the microsponges for the 
active must be optimized for required release rate for given 
period of time. 
Advantages of microsponge drug delivery system 
[18, 19]: 
1. Enhances product performance.  
2. Decreases irritation and increases patient compliance.  
3. Gives elegance to product. It can be incorporated into 
different formulation. 
4. Has good thermal, physical and chemical stability.  
5. Non-irritant, non-mutagenic, non-toxic and non-
allergenic.  
6. Converts fluids into powders to improve material 
handling.  
7. Improves drug bioavailability.  
8. Improves treatment efficiency.  
9. In contrast to other technologies like liposome and 
microencapsulation, MDS has a wide range of chemical 
stability, higher payload and are easy to formulate.  
10. Improved formulation flexibility.  
11. Flexibility to develop novel product forms [20].  
Advantages over other formulations: 
 Microsponges have several advantages over other 
preparations available in the market.  
Conventional formulations: Conventional formulations of 
topical drugs are aimed to work on the outer layers of the 
skin. Such products after application release their active 
ingredients. They deliver a layer of concentrated active 
ingredient which gets rapidly absorbed. This results in 
excessive accumulation of ingredients within the epidermis 
and the dermis. Microsponge system can significantly 
minimize the side effects of drug like irritation without 
decreasing its efficacy through delivering the active 
ingredient gradually to the skin, like MDS Benzoyl peroxide 
formulations which have excellent efficacy with minimal 
irritation [21]. 
Microencapsulation and liposomes: The MDS has 
potential features over other technologies like 
microencapsulation and liposomes. The rate of release of 
actives usually cannot be controlled in microcapsules. The 
actives contained within microcapsules will be released once 
the wall is ruptured. Liposomes have limited capacity, 
difficult formulation, restricted chemical stability and 
microbial instability.  
Ointments: Patient compliance with ointment is reduced 
due to its aesthetically unattractive, viscous and greasy 
nature. Ointments have low efficiency as drug delivery sys-
tems, thus they cause irritation and sensitization because 
these compounds need high concentrations of active 
ingredients for effective treatment. Another drawback of 
Naga Jyothi et el                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(5-s):188-194 
ISSN: 2250-1177                                                                                  [190]                                                                                 CODEN (USA): JDDTAO 
topical formulations is the bad odor, uncontrolled 
evaporation of active ingredient and potential 
incompatibility of drugs with vehicles. The microsponge sys-
tem, however, increases time during which an active resides 
either within epidermis or on skin surface. 
PREPARATION OF MICROSPONGES: 
Method of preparation: 
Method of preparation involves two ways: one is liquid-
liquid suspension polymerization and the other is quasi 
emulsion solvent a diffusion technique, respectively that is 
based on physico-chemical properties of drug to be loaded 
[22]. 
Liquid-liquid suspension polymerization:  
In this method the monomers which are immiscible with 
each other, are first dissolved along with active ingredients 
in a suitable solvent, then they are dispersed in aqueous 
phase consists of surfactant or suspending agents to 
facilitate formation of suspension. The polymerization is 
then activated by increasing temperature, irradiation, or 
addition of a catalyst. The polymerization process results in 
the formation of a reservoir type of system with spherical 
structure. After the polymerization process, the solvent is 
removed leaving the microstructure, i.e., microsponges 
(Fig.2) [23-25]. 
   
 
Fig.2: Microsponge preparation by liquid-liquid suspension polymerization 
 
Quasi-emulsion solvent diffusion: 
Microsponges were also prepared by a quasi-emulsion 
solvent diffusion method (two-step process) using an 
internal phase containing a polymer, such as Eudragit, 
dissolved in ethyl alcohol. Then, the drug is slowly added to 
the polymer solution and dissolved under ultra-sonication at 
35
0
C. A plasticizer such as Tri ethyl citrate (TEC) was added 
in order to aid the plasticity. The internal phase is then 
poured into an external phase containing polyvinyl alcohol 
and distilled water with continuous stirring for 2 hours. 
Then, the solution is filtered to separate the micro sponges. 
The product (micro sponges) was washed and then dried in 
an air- heated oven at 40°C for 12 hours (Fig.3) [23-28].
 
 
Fig.3: Preparation of Microsponges by Quasi- emulsion solvent diffusion method 
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Table 1: Preparation of microsponges by Quasi emulsion solvent diffusion 




 It can be suitably modified to one step or 
two step methods for drug loading. 
Probable entrapment of unreacted monomers and 
solvent traces. Non uniform structure. Requires long 
time for the reaction of monomers. Requires two-step 




No monomer entrapment. Low solvent 
traces. High drug loading. No exposure of 
drug to ambient condition. Size of 
microsponges can be easily controlled by 
controlling the stirring. 
Cannot be used for the loading of water-soluble 
drugs. Requires long time for the reaction of 
monomers. Drug should be soluble in a volatile 
water-soluble solvent. 
Polymers and formulation aids in microsponges:  
Polymers studied for the fabrication of microsponges for the 
oral purposes include Eudragit RS-100, Eudragit RSPO, 
Eudragit S-100, poly lactide-co-glycolic acid, polylactic acid, 
poly divinyl benzene and polyhydroxyl butyrate. Eudragit 
RS-100 formed the most widely used polymer due to its 
versatility enabling the researchers to employ it in various 
ways. It was mostly exploited for the development of colon-
targeted microsponges due to its high transition pH (above 
7) which enabled to protect the release in lower pH. 
Eudragit RSPO also modulated the drug release along with 
enhancing the solubility of the drug by forming a solid 
dispersion like structure. Polylactide-co-glycolic acid and 
Poly lactic acid were studied for delivering the proteins and 
peptides. Microsponges fabricated with these polymers also 
possessed floating ability due to the hydrophobicity of the 
polymer which limited the wetting of the particles with 
aqueous media, thus these microparticles can be employed 
for fabricating floating microsponges. The use large variety 
of polymers for the fabrication of the microsponges showed 
that the method of preparation of microsponges can be 
modified as per the requirement. In addition to polymers 
and active ingredients, some researchers also used tri ethyl 
citrate as plasticizer that help to stabilize the resilient 
property of the microsponges [29]. During the preparation 
of microsponges by quasi-emulsion solvent diffusion 
method, it is reported that the presence of an emulsifier 
having tendency to maintain the viscosity of aqueous phase 
is compulsory [30]. Researchers attempted the use of 
cellulose ethers and PVA for such role and found the use of 
PVA as a better emulsifier. 
Colon targeted drug delivery: 
Colon offers advantages on account of a near neutral pH, 
much longer transit time, greater responsiveness to 
absorption enhancers and reduced digestive enzymatic 
activity [31, 32]. Colon specific drug delivery systems have 
been focused on increasing interest due to the importance of 
this region i.e. gastrointestinal tract. Additionally, colonic 
delivery of drugs may be extremely useful when a delay in 
drug absorption, e.g. in case of diurnal asthma, angina 
pectoris and arthritis is required from a therapeutic point of 
view. Several triggering mechanisms utilizing the 
gastrointestinal transit time of various formulations and the 
change in pH, pressure in the gastrointestinal tract, bacterial 
concentration have been reported to achieve colon specific 
drug delivery [33]. 
Every system has advantage as well as shortcoming. 
Prodrugs, being considered as a new chemical entity from 
regulatory perspective, the similarity in pH between colon, 
small intestine and retention times make the mentioned 
strategies less reliable [34]. However, microflora-activated 
systems formulated making use of non-starch 
polysaccharides are highly promising because the 
polysaccharides remain undigested in the stomach and the 
small intestine and can only be degraded by the vast 
anaerobic microflora of the colon. Furthermore, this strategy 
exploiting the abrupt increase of the bacteria population 
(400 distinct species of bacteria) and corresponding enzyme 
activities will also accomplish greater site-specificity of 
initial drug release [35]. The polysaccharides are also 
inexpensive, naturally occurring and abundantly available 
for colonic drug delivery [36]. 
APPROACHES TO DELIVER THE MOLECULE TO THE 
COLON: 
Coating with polymers: 
The intact molecule can be delivered to the colon by coating 
of the drug molecule with the suitable polymers without 
absorbing at the upper part of the intestine, which degrade 
only in the colon [37]. 
Coating with pH-sensitive polymers: 
The pH-dependent systems exploit pH of the human, GIT 
increases to (pH 7-8) in the distal ileum and it increases 
progressively from the stomach (pH 1-2 which increases to 4 
during digestion, small intestine (pH 6-7) at the site of 
digestion, it increases to 7-8 in the distal ileum. The coating 
of pH-sensitive polymers to the tablets, capsules or pellets 
provide delayed release and protect the active drug from 
gastric fluid [38]. 
Coating with biodegradable polymers: 
The bio environment inside the human GIT is characterized 
by the presence of complex microflora especially the colon 
that is rich in microorganisms that are involved in the 
process of reduction of dietary component or other 
materials. Drugs which are coated with the polymers,  are 
showing degradability due to the influence of colonic 
microorganisms, can be exploited in designing drugs for 
colon targeting [39]. 
EVALUATION TESTS OF MICROSPONGES: 
 Particle Size and Size Determination [40, 41] 
Morphology and surface topography [42] 
Determination of pH [43] 
Determination of loading efficiency and production yield 
[44]  
Determination of true density [45] 
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Characterization of pore structure [46] 
Dissolution Test [47] 
Compatibility Studies [48] 
Kinetics of release [49] 
Scanning Electron Microscopy (SEM) [50] 
Fourier transform infrared spectroscopy (FTIR) [51] 
APPLICATIONS OF MICROSPONGES: 
Microsponges can be used in variety of applications. It is 
used mostly for topical and recently for oral administration 
[52-56]. Several patents have reported that it can be used as 
an excipient due to its high loading capacity and sustained 
release ability. 
In oral drug delivery: 
The oral route is considered the most common route of 
administration due to its ease of access, high capability of 
dissolving many drugs, and low toxicity. Although it is easy 
and safe, it is not compatible with all administered drugs, as 
drugs that have short life time that are excreted rapidly after 
administration, drugs that destroyed by the acidity of the 
stomach or bile juice secreted in the intestine, or drug that 
are needed to be in the colon to treat some medical 
condition. This made to developing methods for controlling 
the release of the drug [57-61]. In oral applications, the 
microsponge system has been shown to increase the rate of 
solubilisation of poorly water soluble drugs by entrapping 
such drugs in the microsponge system's pores. Controlled 
oral delivery of ibuprofen microsponges is achieved with an 
Eudragit RS, acrylic polymer, by changing their intraparticle 
density. Sustained release formulation of chlorpheniramine 
maleate, microsponges is prepared by the dry impact 
blending method, for oral drug delivery. Controlled oral 
delivery of Ketoprofen is prepared by quasi-emulsion 
solvent diffusion method with Eudragit RS 100 polymer and 
afterwards tablets of microsponges were prepared by the 
direct compression method. Colon-specific, controlled 
delivery of Flurbiprofen and Eudragit RS 100 were prepared 
by quasi-emulsion solvent diffusion method.  FLB was 
entrapped into a commercial Microsponge 5640 system 
using entrapment method [62]. Curcumin loaded 
microsponges were prepared by quasi emulsion solvent 
diffusion method using Eudragit polymer and water soluble 
porogen. Microsponges were optimized using 32 full factorial 
design. Studies revealed that microsponges prevented the 
premature release of curcumin in upper GIT and specifically 
released the drug at colonic pH [63]. Prednisolone-loaded 
microsponges for colon specific drug delivery were prepared 
by quasi-emulsion solvent diffusion method with Eudragit 
RS 100 as a polymer. Oral controlled release of 
Prednisolone-loaded microsponges is formulated to 
minimize the proximal absorption, allow high drug 
concentration in the colon and reduced side-effect [64]. 
Sustained release of 5-Fluorouracil (5-FU) is prepared by Oil 
in oil emulsion solvent diffusion method with Eudragit 
RS100 polymer for treatment of colon cancer. The 
formulation of 5-FU Microsponges is used to enhance the 
entrapping efficiency of more than 95% [65]. 
Topical: 
Many topical formulations are based on microsponge drug 
delivery system. As microsponge is polymer-based, allows 
binding or sustaining a large content of drug. Although they 
are microscopic in size, these systems are too large to pass 
through the stratum corneum when incorporated into 
topical products [66-72]. Benzoyl peroxide (BPO) is 
commonly used in topical formulations for the treatment of 
acne, skin irritation as a common side effect. It has been 
shown that controlled release of Benzoyl peroxide as a 
delivery system to the skin could reduce the side effect while 
reducing percutaneous absorption. Benzoyl Peroxide is 
prepared by emulsion solvent diffusion method, aqueous 
phase containing polyvinyl alcohol to this add organic 
internal phase which contains ethyl cellulose and 
dichloromethane by suspension polymerization of styrene 
and divinyl benzene. The prepared microsponges were 
dispersed in gel base and they are evaluated for anti-
bacterial and skin irritancy. The system containing free BPO 
can release the drug at greater rate than the entrapped 
system. Topical delivery system was successfully developed 
with reduced irritancy. 
Microsponge for Bone and Tissue Engineering Bone-
substitute 
By mixing the pre polymerized powders of polymethyl 
methacrylate and liquid methyl methacrylate monomer with 
two aqueous dispersions of calcium deficient hydroxyapatite 
powders and tricalcium phosphate grains compounds were 
obtained. The final composites appeared to be porous and 
acted as microsponges. According to the biodegradation of 
the sponge matrix, when collagen sponge sheet was 
incorporated in the mouse sub-cutis, basic fibroblast growth 
factor (bFGF) was sustained released and exhibited local 
angiogenic activity in a dose-dependent manner. These 
suggest the significance and therapeutic utility of the type I 
collagen as a reservoir of bFGF [73-81]. 
CONCLUSION: 
Microsponges are identified as potential, novel targeting for 
controlled release of drug molecule to the various parts of 
GIT including ascending colon and stomach. Based on the 
research work in the microsponges reveals that it can able to 
manage the dosing frequency effectively. Apart from the 
above medicinal advantage, microsponges can able to 
deliver the drug at specific site on specific rate with a 
improved, safety and reduced toxicity. In this view, we 
exclusively reviewed about different methods to prepare the 
microsponges. Further the characterizations of 
microsponges were effectively revealed. Microsponge 
delivery technology is more likely to become valuable for 
various therapeutic applications in the future. Microsponges 
has got a lot of potential and is a emerging field which is 
needed to be explored soon with extensive research work 
for the proper development of this technology, as this 
system has a vast scope for development of various novel 
pharmaceutical applications.  
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